Cargando…
Lipidomics and proteomics: An integrative approach for early diagnosis of dementia and Alzheimer’s disease
Alzheimer’s disease (AD) is the most common neurodegenerative disorder and considered to be responsible for majority of worldwide prevalent dementia cases. The number of patients suffering from dementia are estimated to increase up to 115.4 million cases worldwide in 2050. Hence, AD is contemplated...
Autores principales: | Tiwari, Virendra, Shukla, Shubha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946989/ https://www.ncbi.nlm.nih.gov/pubmed/36845373 http://dx.doi.org/10.3389/fgene.2023.1057068 |
Ejemplares similares
-
Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2022) -
The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer’s Disease
por: Martins, Ian James
Publicado: (2016) -
Transcriptome analysis reveals potential marker genes for diagnosis of Alzheimer’s disease and vascular dementia
por: Wang, Li, et al.
Publicado: (2022) -
Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages
por: Peña-Bautista, Carmen, et al.
Publicado: (2021) -
Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease
por: Xu, Jin, et al.
Publicado: (2020)